Stratos Wealth Partners’s PetMed Express PETS Stock Holding History

Stratos Wealth Partners’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-826	Closed	-$27K	–	2019
2018 Q3	$27K	Buy	+826	New	+$30.9K	﹤0.01%	1731
2018 Q2	–	Sell	-1,620	Closed	-$68K	–	2117
2018 Q1	$68K	Buy	1,620 +220	+16%	+$10.2K	﹤0.01%	1411
2017 Q4	$64K	Buy	+1,400	New	+$55.2K	﹤0.01%	1402

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return

Stratos Wealth Partners's PETS Position: Q4 2018 in Review

Stratos Wealth Partners sold out of PetMed Express (PETS) in Q4 2018, closing a stake of 826 shares — an estimated $27K sold.

Stratos Wealth Partners first reported a position in PETS in Q4 2017 and held it in 3 quarters. The position peaked at $68K in Q1 2018. 200 funds tracked by Wall St. Rank hold PETS as of Q4 2018.

Stratos Wealth Partners reported no remaining PetMed Express position as of Q4 2018 after selling out during the quarter.
Stratos Wealth Partners sold 826 PetMed Express shares in Q4 2018, an estimated $27K.
Stratos Wealth Partners first reported a position in PetMed Express in Q4 2017 and held it in 3 quarters.
Stratos Wealth Partners's PetMed Express position peaked at $68K in Q1 2018.
200 funds tracked by Wall St. Rank held PetMed Express as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.